Skip to content

Effectiveness of ''Liu-Zi-Jue'' combined with respiratory muscle training for respiratory function in novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial

Effectiveness of ''Liu-Zi-Jue'' combined with respiratory muscle training for respiratory function in COVID-19 patients: a demonstration study for the key techniques

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030933
Enrollment
Unknown
Registered
2020-03-18
Start date
2020-03-31
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Group 1:Liuzijue exercise
Group 2:Respiratory muscle training
Group 3:Liuzijue exercise combined with respiratory muscle training

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with COVID-19 [in accordance with the diagnostic criteria of the Notice on Printing and Distributing COVID-19 Diagnosis and Treatment Plan (Trial Implementation Version 6th) issued by the National Health and Medical Commission], and meets the discharge criterion; 2. Aged 18 to 75 years old; 3. Be consious; 4. Volunteer to participate in the study and sign the informed consent form, and be able to understand, receive rehabilitation guidance and implement it.

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with the critical type of COVID-19 [in accordance with the diagnostic criteria of the Notice on Printing and Distributing COVID-19 Diagnosis and Treatment Plan (Trial Implementation Version 6th) issued by the National Health and Medical Commission], and with unstable vital signs; 2. Patients with severe primary disease of liver, kidney, hematological and endocrine system; 3. Pregnant or lactating women; 4. Patients with a history of psychosis, substance abuse or dependence; 5. Those who participate in other clinical trials within 3 months when screening; 6. Patients with other diseases being treated with medications and affecting the study observation; 7. Other patients that considered unsuitable for the clinical trial by the investigators.

Design outcomes

Primary

MeasureTime frame
Maximal inspiratory pressure;Respiratory muscle evaluation;

Secondary

MeasureTime frame
Dyspnea evaluation;6-Minute Walking Test;Activity of Daily Living;Evluation of International Classification of Functioning, Disability and Health;Hamilton Anxiety Scale;Hamilton Depression Scale;Quality of Life;

Countries

China

Contacts

Public ContactFeng Zhen

The First Affiliated Hospital of Nanchang University

fengzhenly@sina.com+86 13970038111

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026